AURKA and breast cancer: Although previous studies in breast cancer cellular models showed that sensitivity to low-dose FTY720 could be predicted by a high mRNA expression of AURKA (unpublished data), this study shows that sensitivity to FTY720 in CRC cell lines cannot be predicted using this model.